Variant report

Variant	nsv894109
Chromosome Location	chr9:136512515-136522985
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:56)
CpG islands
(count:305)
Chromatin interactive
region (count:10)
LncRNA
region (count:10)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:56 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BRCA1	chr9:136512610-136512613	Hela-S3	cervix:	n/a	n/a
2	BRCA1	chr9:136522095-136522108	HepG2	liver:	n/a	n/a
3	CTCF	chr9:136521724-136521806	H1-hESC	embryonic stem cell:	n/a	n/a
4	CTCF	chr9:136521736-136521776	GM12892	blood:	n/a	n/a
5	CTCF	chr9:136521739-136521834	Spleen_OC	spleen:	n/a	n/a
6	CTCF	chr9:136522540-136522712	Kidney_OC	kidney:	n/a	n/a
7	CTCF	chr9:136521642-136521910	T-47D	breast:	n/a	n/a
8	CTCF	chr9:136521701-136521816	MCF-7	breast:	n/a	n/a
9	CTCF	chr9:136521700-136521850	WERI-Rb-1	eye:	n/a	n/a
10	CTCF	chr9:136521715-136521827	MCF-7	breast:	n/a	n/a
11	CTCF	chr9:136521720-136521870	HMEC	breast:	n/a	n/a
12	CTCF	chr9:136522530-136522680	Lung_OC	lung:	n/a	n/a
13	CTCF	chr9:136521731-136521806	MCF-7	breast:	n/a	n/a
14	CTCF	chr9:136521702-136521828	NHEK	skin:	n/a	n/a
15	CTCF	chr9:136522578-136522713	Fibrobl	skin:	n/a	n/a
16	CTCF	chr9:136521736-136521809	Lung_OC	lung:	n/a	n/a
17	CTCF	chr9:136521660-136521810	HepG2	liver:	n/a	n/a
18	CTCF	chr9:136521652-136521882	HepG2	liver:	n/a	n/a
19	FOSL2	chr9:136522577-136525475	HepG2	liver:	n/a	n/a
20	JUND	chr9:136522524-136522680	H1-hESC	embryonic stem cell:	n/a	n/a
21	JUND	chr9:136522472-136522758	HepG2	liver:	n/a	n/a
22	POLR2A	chr9:136520496-136520510	HepG2	liver:	n/a	n/a
23	POLR2A	chr9:136521557-136521598	H1-hESC	embryonic stem cell:	n/a	n/a
24	POLR2A	chr9:136519885-136520048	HepG2	liver:	n/a	n/a
25	POLR2A	chr9:136522700-136522713	HepG2	liver:	n/a	n/a
26	POLR2A	chr9:136521205-136521743	HepG2	liver:	n/a	n/a
27	POLR2A	chr9:136518192-136518267	GM12878	blood:	n/a	n/a
28	POLR2A	chr9:136520264-136520480	HepG2	liver:	n/a	n/a
29	POLR2A	chr9:136520910-136521135	HepG2	liver:	n/a	n/a
30	POLR2A	chr9:136522809-136523106	HepG2	liver:	n/a	n/a
31	POLR2A	chr9:136521389-136521979	HepG2	liver:	n/a	n/a
32	POLR2A	chr9:136521791-136522646	HepG2	liver:	n/a	n/a
33	POLR2A	chr9:136513019-136513116	MCF-7	breast:	n/a	n/a
34	POLR2A	chr9:136520195-136520331	HepG2	liver:	n/a	n/a
35	POLR2A	chr9:136522663-136522677	HepG2	liver:	n/a	n/a
36	POLR2A	chr9:136517430-136517851	HepG2	liver:	n/a	n/a
37	POLR2A	chr9:136518175-136519024	HepG2	liver:	n/a	n/a
38	RAD21	chr9:136521688-136521860	H1-hESC	embryonic stem cell:	n/a	chr9:136521797-136521807
39	RAD21	chr9:136521644-136521900	HepG2	liver:	n/a	chr9:136521797-136521807
40	RAD21	chr9:136521736-136521798	Hela-S3	cervix:	n/a	n/a
41	RAD21	chr9:136521701-136521733	HepG2	liver:	n/a	n/a
42	RAD21	chr9:136521548-136522019	H1-hESC	embryonic stem cell:	n/a	chr9:136521797-136521807
43	RCOR1	chr9:136514412-136514625	K562	blood:	n/a	n/a
44	RCOR1	chr9:136514369-136514671	K562	blood:	n/a	n/a
45	UBTF	chr9:136520902-136521055	K562	blood:	n/a	n/a
46	USF1	chr9:136518749-136519055	A549	lung:	n/a	chr9:136518896-136518907
47	USF1	chr9:136518741-136519020	A549	lung:	n/a	chr9:136518896-136518907
48	USF1	chr9:136518686-136519159	ECC-1	luminal epithelium:	n/a	chr9:136518896-136518907
49	USF1	chr9:136518759-136519050	A549	lung:	n/a	chr9:136518896-136518907
50	USF1	chr9:136518732-136518943	K562	blood:	n/a	chr9:136518896-136518907

(count:305 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:136522662-136522712	HRE	kidney:	n/a
2	chr9:136522662-136522712	AG09309	skin:	n/a
3	chr9:136522662-136522712	A549	lung:	n/a
4	chr9:136522716-136522766	NHBE	bronchial:	n/a
5	chr9:136522662-136522712	ovcar-3	ovarian:	n/a
6	chr9:136522927-136522977	NT2-D1	testis:	n/a
7	chr9:136522716-136522766	GM12878	blood:	n/a
8	chr9:136520852-136520902	U87	brain:	n/a
9	chr9:136520852-136520902	PANC-1	pancreas:	n/a
10	chr9:136520852-136520902	HUVEC	blood vessel:	n/a
11	chr9:136522716-136522766	HRCEpiC	kidney:	n/a
12	chr9:136522716-136522766	HRE	kidney:	n/a
13	chr9:136516616-136516666	NT2-D1	testis:	n/a
14	chr9:136522927-136522977	ovcar-3	ovarian:	n/a
15	chr9:136522662-136522712	HepG2	liver:	n/a
16	chr9:136522662-136522712	HEK293	kidney:	embryo
17	chr9:136522662-136522712	T-47D	breast:	n/a
18	chr9:136522716-136522766	BE2_C	brain:	n/a
19	chr9:136516616-136516666	HRCEpiC	kidney:	n/a
20	chr9:136522716-136522766	HIPEpiC	eye:	n/a
21	chr9:136522927-136522977	HAEpiC	amniotic membrane:	n/a
22	chr9:136522716-136522766	PrEC	prostate:	n/a
23	chr9:136522927-136522977	HPAEpiC	pulmonary alveolar:	n/a
24	chr9:136522927-136522977	AoSMC	blood vessel:	n/a
25	chr9:136522927-136522977	BE2_C	brain:	n/a
26	chr9:136522927-136522977	SK-N-SH	brain:	n/a
27	chr9:136522662-136522712	SK-N-SH_RA	brain:	n/a
28	chr9:136522927-136522977	SAEC	small airway:	n/a
29	chr9:136522716-136522766	ECC-1	luminal epithelium:	n/a
30	chr9:136520852-136520902	HCT-116	colon:	n/a
31	chr9:136522716-136522766	Hela-S3	cervix:	n/a
32	chr9:136522927-136522977	MCF10A-Er-Src	breast:	n/a
33	chr9:136522927-136522977	SK-N-SH_RA	brain:	n/a
34	chr9:136516616-136516666	HMEC	breast:	n/a
35	chr9:136520852-136520902	HCM	heart:	n/a
36	chr9:136522716-136522766	PANC-1	pancreas:	n/a
37	chr9:136516616-136516666	NHBE	bronchial:	n/a
38	chr9:136522927-136522977	AG04450	lung:	fetal
39	chr9:136520852-136520902	HRCEpiC	kidney:	n/a
40	chr9:136522662-136522712	GM06990	blood:	n/a
41	chr9:136522662-136522712	GM12878	blood:	n/a
42	chr9:136522716-136522766	AG04450	lung:	fetal
43	chr9:136522927-136522977	ProgFib	skin:	n/a
44	chr9:136522927-136522977	H1-hESC	embryonic stem cell:	embryo
45	chr9:136522927-136522977	HCF	heart:	n/a
46	chr9:136522716-136522766	HEEpiC	esophagus:	n/a
47	chr9:136522716-136522766	HPAEpiC	pulmonary alveolar:	n/a
48	chr9:136520852-136520902	NH-A	brain:	n/a
49	chr9:136516616-136516666	BE2_C	brain:	n/a
50	chr9:136522927-136522977	HCPEpiC	choroid plexus:	n/a

(count:10 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr9:136514960..136517246-chr9:136545398..136548011,2	K562	blood:
2	chr9:136510698..136512936-chr9:136554635..136557267,2	MCF-7	breast:
3	chr9:136518974..136521399-chr9:136523004..136525968,3	K562	blood:
4	chr9:136514740..136517614-chr9:136519360..136521535,2	K562	blood:
5	chr9:136518974..136520647-chr9:136523004..136525968,2	K562	blood:
6	chr9:136500673..136503407-chr9:136511410..136514325,2	MCF-7	breast:
7	chr9:136492846..136495441-chr9:136522709..136525633,2	MCF-7	breast:
8	chr9:136514740..136517614-chr9:136519360..136521535,2	K562	blood:
9	chr9:136508750..136511596-chr9:136514989..136519879,4	K562	blood:
10	chr9:136521310..136521871-chr9:136591160..136591908,2	MCF-7	breast:

(count:10 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SARDH-1	chr9:136522249-136522530	NR_102735
2	lnc-SARDH-1	chr9:136522249-136524916	NONHSAT135333
3	lnc-SARDH-1	chr9:136522611-136522653	NONHSAT135334
4	lnc-SARDH-1	chr9:136519709-136521659	NR_102735
5	lnc-SARDH-1	chr9:136519271-136521659	NONHSAT135332
6	lnc-SARDH-1	chr9:136519708-136522571	NONHSAT135334
7	lnc-SARDH-1	chr9:136522216-136525145	NONHSAT135332
8	lnc-SARDH-1	chr9:136519317-136521659	NONHSAT135333
9	lnc-SARDH-1	chr9:136519708-136521659	ENSG00000225756.1
10	lnc-SARDH-1	chr9:136522249-136522435	ENSG00000225756.1

No data

Variant related genes	Relation type
DBH-AS1	TF binding region
DBH-AS1	CpG island
ENSG00000123454	chromatin interactions

Extended variants
information (count: 682 )
Associated
traits (count: 80 )

Variant overlapped rSNPs/rCNVs (count:682 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2797853	chr9:136512515-136512516	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs577693733	chr9:136512549-136512550	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs544589805	chr9:136512550-136512551	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs556579332	chr9:136512581-136512582	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs575531717	chr9:136512611-136512612	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs542868457	chr9:136512640-136512641	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs137940656	chr9:136512641-136512642	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs528653954	chr9:136512654-136512655	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs540496379	chr9:136512658-136512659	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs142419418	chr9:136512676-136512677	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs377200561	chr9:136512723-136512724	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs3025410	chr9:136512736-136512737	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs550988870	chr9:136512739-136512740	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs569226819	chr9:136512743-136512744	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs144653396	chr9:136512756-136512757	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs549225358	chr9:136512766-136512767	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs567470945	chr9:136512771-136512772	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs534794856	chr9:136512772-136512773	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs552927287	chr9:136512810-136512811	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs142937719	chr9:136512839-136512840	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs559490825	chr9:136512842-136512843	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs538394186	chr9:136512846-136512847	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs563876085	chr9:136512855-136512856	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs3025411	chr9:136512906-136512907	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs371329687	chr9:136512912-136512913	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs368526002	chr9:136512919-136512920	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs200156793	chr9:136512936-136512937	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs372914149	chr9:136512937-136512938	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs199926239	chr9:136512962-136512963	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs45439392	chr9:136512970-136512971	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs369664655	chr9:136512971-136512972	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs267606761	chr9:136512976-136512977	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs565384089	chr9:136512989-136512990	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs202213535	chr9:136512992-136512993	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs372772330	chr9:136512998-136512999	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs151174779	chr9:136513018-136513019	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs140171769	chr9:136513019-136513020	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs201759717	chr9:136513026-136513027	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs368994366	chr9:136513027-136513028	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs75215331	chr9:136513028-136513029	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs200103371	chr9:136513037-136513038	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs375806157	chr9:136513058-136513059	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs370974965	chr9:136513059-136513060	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs373518838	chr9:136513081-136513082	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs77984399	chr9:136513082-136513083	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs548319420	chr9:136513089-136513090	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs200281127	chr9:136513090-136513091	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs370844365	chr9:136513095-136513096	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs374568498	chr9:136513107-136513108	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs546771143	chr9:136513108-136513109	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:80)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Medulloblastoma	21979893	CNVD
microdeletion syndrome	16199537	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Urothelial carcinoma	21177765	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Myelofibrosis	22110671	CNVD
Leukemia	17361228	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Glioblastoma	16823260	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Non-small cell lung cancer	21044232	CNVD
Brain cancer	20823417	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Renal cell carcinoma	19461508	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Heart disease	21282601	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	17603634	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	18632612	CNVD
Cardiac fibroma	18329553	CNVD
Lung cancer	19147751	CNVD
Melanoma	18172304	CNVD
Cervical cancer	16585170	CNVD
Ependymoma	19289631	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Cervical cancer	17311676	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Gastric cancer	17908304	CNVD
Breast cancer	16608533	CNVD
Metanephric adenoma	20802469	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Chordoma	18071362	CNVD
small cell lung cancer	20016488	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Kleefstra Syndrome	21538692	CNVD
Disorders of sex development	22290220	CNVD
Cancer	21183584	CNVD
Chronic myelomonocytic leukemia	16760666	CNVD
Abnormal phenotypes	18644119	CNVD
Ovarian cancer	21720365	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Sudden cardiac death	19188705	CNVD
Myoepithelioma	18604193	CNVD
Tuberous sclerosis	19566914	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Breast cancer	21364760	CNVD
Cancer	20581869	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Breast cancer	21509527	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Hepatocellular carcinoma	22174799	CNVD
Bladder cancer	21909424	CNVD
Cancer	17160897	CNVD
Ependymoma	20639864	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	20932292	CNVD
T-cell lymphomas	22341440	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:132 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:136507600-136512600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
2	chr9:136508800-136514600	Weak transcription	Spleen	Spleen
3	chr9:136511400-136512800	Weak transcription	Pancreas	Pancrea
4	chr9:136512000-136512600	Enhancers	Primary T helper cells PMA-I stimulated	--
5	chr9:136512000-136512800	Enhancers	Primary T helper naive cells fromperipheralblood	blood
6	chr9:136512000-136513400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
7	chr9:136512200-136513000	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
8	chr9:136512400-136512600	Enhancers	Fetal Thymus	thymus
9	chr9:136512400-136512800	Enhancers	Primary T cells from cord blood	blood
10	chr9:136512400-136512800	Enhancers	Primary T helper naive cells from peripheral blood	blood
11	chr9:136512600-136513000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
12	chr9:136513000-136513200	Enhancers	Brain Inferior Temporal Lobe	brain
13	chr9:136513000-136513200	Enhancers	Pancreas	Pancrea
14	chr9:136513000-136513400	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
15	chr9:136513200-136513400	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
16	chr9:136513400-136513600	Bivalent Enhancer	Ganglion Eminence derived primary cultured neurospheres	brain
17	chr9:136513400-136514800	Weak transcription	H1 Cell Line	embryonic stem cell
18	chr9:136513400-136516200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
19	chr9:136514400-136515400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
20	chr9:136514600-136515000	ZNF genes & repeats	Spleen	Spleen
21	chr9:136514800-136515000	Bivalent Enhancer	Ganglion Eminence derived primary cultured neurospheres	brain
22	chr9:136515000-136523400	Weak transcription	Spleen	Spleen
23	chr9:136516200-136516400	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
24	chr9:136516200-136517000	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
25	chr9:136517000-136517200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
26	chr9:136517200-136520000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
27	chr9:136518400-136519000	Bivalent Enhancer	HepG2	liver
28	chr9:136518600-136518800	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
29	chr9:136518600-136518800	Enhancers	Liver	Liver
30	chr9:136518600-136518800	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
31	chr9:136518800-136519000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
32	chr9:136519600-136520200	Enhancers	Breast Myoepithelial Primary Cells	Breast
33	chr9:136519600-136521200	Enhancers	Primary T cells from cord blood	blood
34	chr9:136520000-136521600	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
35	chr9:136520000-136522000	Bivalent Enhancer	Fetal Thymus	thymus
36	chr9:136520200-136520400	Enhancers	H9 Cell Line	embryonic stem cell
37	chr9:136520200-136520400	Bivalent Enhancer	Primary mononuclear cells fromperipheralblood	Blood
38	chr9:136520200-136520400	Bivalent Enhancer	HMEC	breast
39	chr9:136520200-136520600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
40	chr9:136520200-136520600	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
41	chr9:136520200-136521000	Enhancers	H1 Cell Line	embryonic stem cell
42	chr9:136520200-136521800	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
43	chr9:136520200-136521800	Enhancers	Primary T helper naive cells fromperipheralblood	blood
44	chr9:136520200-136522400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
45	chr9:136520200-136522800	Enhancers	Brain Germinal Matrix	brain
46	chr9:136520200-136524200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
47	chr9:136520400-136520600	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
48	chr9:136520400-136520600	Enhancers	Primary T helper naive cells from peripheral blood	blood
49	chr9:136520400-136520600	Enhancers	Primary T helper cells fromperipheralblood	blood
50	chr9:136520400-136521200	Bivalent Enhancer	Fetal Muscle Leg	muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links